Preferred Pharmaceuticals, Inc.
25 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Preferred Pharmaceuticals, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-04-15FDA-DrugClass IIStop using Preferred Pharmaceuticals Artificial Tears
Lack of Assurance of Sterility
- 2025-05-07FDA-DrugClass IIClindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
cGMP Deviations
- 2024-09-04FDA-DrugClass IIIbuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Failed Impurities/Degradation Specifications - at 18-month Stability testing
- 2024-05-29FDA-DrugClass IIDuloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
- 2023-07-12FDA-DrugClass IITizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.
Failed Stability Specifications
- 2023-04-12FDA-DrugClass IIGlimepiride Tablets USP, 4 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8066-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IITadalafil Tablets, USP, 20 mg, 7-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-8153-7
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IISimvastatin Tablets, USP, 40 mg, Packaged as: a) 90-count bottle (NDC 68788-9868-9); b) 60-count bottle (NDC 68788-9868-6); c) 30-count bottle (NDC 68788-9868-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IISimvastatin Tablets, USP, 20 mg, Packaged as: a) 90-count bottle (NDC 68788-9869-9); b) 60-count bottle (NDC 68788-9869-6); c) 30-count bottle (NDC 68788-9869-3), Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IISimvastatin Tablets, USP, 80 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9429-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IISimvastatin Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, lnc., Durham, NC 27703, NDC 68788-9747-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIPravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8215-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIRosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIRosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDC 68788-7086-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIMontelukast Sodium Tablets, USP, 10 mg, packaged in: a) 30-count bottle (NDC 68788-9438-3); b) 60-count bottle (NDC 68788-9438-6); c) 90-count bottle (NDC 68788-9438-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIGlimepiride Tablets, USP, 2 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8095-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIFinasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703.
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIDoxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIDoxazosin Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7328-1
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIClopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIAtorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIAtorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7630-9
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- 2023-04-12FDA-DrugClass IIAlprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
- 2023-04-12FDA-DrugClass IIAlprazolam Tab, USP 0.5mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7595-3), b) 60-count bottle (NDC 68788-7595-6), c) 90-count bottle (NDC 68788-7595-9); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
- 2023-04-12FDA-DrugClass IIAlprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL. Ins:NDC 68788-7594-3
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Get notified about new Preferred Pharmaceuticals, Inc. recalls
Free weekly digest. We email when a new federal recall affects Preferred Pharmaceuticals, Inc. or anything else in your household.
Get the Sunday Brief